Using electronic tools to identify risks of opioid misuse and overdose
Feasibility of Electronic Screening to Identify Risk of Opioid Misuse and Overdose
This study is testing a new digital way to help doctors and pharmacists better identify patients who might be at risk for misusing opioids, so they can provide the right support and education, especially about using naloxone to prevent overdoses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oprems LLC NIH-funded |
| Lab location | 1 site (Northbrook, United States) |
| Project ID | NIH-10822394 on NIH RePORTER |
What this research studies
This research aims to enhance the screening process for patients prescribed opioids by transitioning from a paper-based system to a digital platform. By utilizing tablet PCs, the project seeks to improve the consistency and effectiveness of identifying individuals at risk for opioid misuse and overdose. The program, known as ONE, has already shown promising results in community pharmacies, where it has significantly increased the dispensing of naloxone, a medication that can reverse opioid overdoses. The goal is to provide targeted interventions and education to patients based on their screening results.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients who are currently prescribed opioid medications and may be at risk for misuse.
Not a fit: Patients who are not prescribed opioids or who do not have any risk factors for opioid misuse may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention strategies for opioid misuse and overdose, ultimately saving lives.
How similar studies have performed: Previous implementations of the ONE program have shown success in increasing naloxone dispensing rates, indicating that similar approaches may be effective.
Where this research is happening
Northbrook, United States
- Oprems LLC — Northbrook, United States (Active)
Researchers
- Principal investigator: Ferrarese, Nick — Oprems LLC
- Study coordinator: Ferrarese, Nick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.